Non-Hodgkin's Lymphoma, Phase I

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

Volunteers
Health Professionals

What is the purpose of this trial?

This is a Phase 1, two-part, multicenter study to evaluate ELA026 in participants ≥18 years old with relapsed/refractory TCM following any line of prior therapy who are eligible for investigational treatments.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Daniel Moncayo

daniel.moncayo@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Francine Foss, MD
Professor of Medicine (Hematology) and of Dermatology; Director, Multidisciplinary T cell Lymphoma Program, Hematology; Scientific Leader, Lymphoma CRT, Yale Cancer Center

Sub-Investigators

Last Updated
05/20/2026
Study IRB
#2000041981